Skip to main content
. Author manuscript; available in PMC: 2013 Jul 22.
Published in final edited form as: Pharm Res. 2010 May 26;27(8):1703–1712. doi: 10.1007/s11095-010-0170-2

Table 1.

Information of excipients used in the current studies

Abbr. Excipient name Dosea Functionalityb Source
SDc Amorphous fumed silicon dioxide 0.1 mg/ml Glidant Degussa Corp.; Ridgefield, NJ
CA Citric acid 0.4 mg/ml Acidifier Spectrum; Gardena, CA
CCSc Croscarmellose sodium 2.0 mg/ml Disintegrant FMC; Belgium
X-PVPc Crospovidone 2.0 mg/ml Disintegrant ISP Technologies; Wayne, NJ
DCPc Dicalcium phosphate dehydrate 20 mg/ml Filler/binder JRS Pharma; Germany
FAc Fumaric acid 4.0 mg/ml Acidifier Sigma; St. Louis, MO
HPMC Hydroxypropyl methylcellulose 20 mg/ml Filler/binder Dow Chemical; Midland, MI
LAC Lactose 20 mg/ml Filler/binder DMV International; The Netherlands
MgStrc Magnesium stearate 0.1 mg/ml Lubricant Mallincrodt; St. Louis, MO
MA Malic acid 0.4 mg/ml Acidifier Spectrum; Gardena, CA
MCCc Microcrystalline cellulose 20 mg/ml Filler/binder FMC; Philadelphia, PA
PEG-3350 Polyethylene glycol 3350 10 mg/ml Plasticizer Dow Chemical; Midland, MI
PS-80 Polysorbate-80 1.0 – 0.0001 mg/ml Surfactant Spectrum; Gardena, CA
PVP Povidone 2.0 mg/ml Filler/binder BASF; Germany
PgSc Pregelatinized starch 3.0 mg/ml Filler/binder National Starch Food; Bridgewater, NJ
PG Propylene glycol 0.4 mg/ml Plasticizer Dow Chemical; Midland, MI
SLS Sodium lauryl sulfate 2.0 mg/ml Surfactant Sigma; St. Louis, MO
SSGc Sodium starch glycolate 1.0 mg/ml Disintegrant Mendell; Patterson, NY
SUC Sucrose 10 mg/ml Filler/binder JRS Pharma; Patterson, NY
a

Dose is defined as the amount of each excipient estimated to be in a tablet or capsule containing a total of 500mg of excipient dissolved in 25ml luminal volume.

b

Individual excipient compounds are assigned to one functionality group, but may have more than one function.

c

Excipient concentration was not completely soluble in PBS.